Nonalcoholic steatohepatitis: Recent advances from experimental models to clinical management

Clinical Biochemistry

Volumn 38, Issue 3, 2005, Pages 203-217

  Portincasa, Piero ^a   Grattagliano, Ignazio ^a   Palmieri, Vincenzo O ^a   Palasciano, Giuseppe ^a  

^a UNIVERSITY OF BARI MEDICAL SCHOOL   (Italy)

Author keywords

Antioxidants; Breath test; Choline deficient diet; Fatty liver; Insulin resistance; Microsomes; Mitochondria; Nonalcoholic steatohepatitis; Oxidative stress; Peroxisomes

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ACETYLCYSTEINE; ALPHA TOCOPHEROL; AMINOTRANSFERASE; CIPROFIBRATE; FATTY ACID; GEMFIBROZIL; METFORMIN; PREBIOTIC AGENT; PROBIOTIC AGENT; ROSIGLITAZONE; S ADENOSYLMETHIONINE; URSODEOXYCHOLIC ACID;

AMINOTRANSFERASE BLOOD LEVEL; BIOCHEMISTRY; CELL ACTIVITY; CELL DEATH; CELL FUNCTION; CLINICAL FEATURE; DIAGNOSTIC PROCEDURE; DIET; DIET RESTRICTION; DIET SUPPLEMENTATION; DISEASE COURSE; ENZYME ACTIVATION; EXERCISE; FATTY LIVER; FOLLOW UP; HUMAN; INFLAMMATION; INSULIN RESISTANCE; LIVER CIRRHOSIS; LIVER DISEASE; LIVER DYSFUNCTION; LIVER FUNCTION TEST; LIVER HISTOLOGY; LIVER TRANSPLANTATION; MICROSOME; MITOCHONDRION; MOLECULAR INTERACTION; MORPHOLOGY; NECROSIS; NONALCOHOLIC FATTY LIVER; NONHUMAN; OXIDATION REDUCTION REACTION; PATHOGENESIS; PATHOPHYSIOLOGY; PEROXISOME; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; RISK ASSESSMENT; TREATMENT OUTCOME; UPREGULATION; WEIGHT REDUCTION;

EID: 13544258741     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2004.10.014     Document Type: Review

References (187)

1. J. Ludwig, R.T. Viggiano, D.B. McGill, and B.J. Oh Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease Mayo Clin. Proc. 55 1980 434 438
2. F. Trevisani, A. Colantoni, P. Caraceni, and D.H. Van Thiel The use of donor fatty liver for liver transplantation: a challenge or a quagmire? J. Hepatol. 22 1996 114 121
3. S. Bellentani, C. Tiribelli, and G. Saccoccio Prevalence of chronic liver disease in the general population of northern Italy: the Dionysos study Hepatology 20 1994 1442 1449
4. R.J. Ploeg, A.M. D'Alessandro, and S.J. Knechtle Risk factors for primary dysfunction after liver transplantation: a multivariate analysis Transplantation 55 1993 807 813
5. O.F.W. James, and C.P. Day Non-alcoholic steatohepatitis (NASH): a disease of emerging identity and importance J. Hepatol. 29 1998 495 501
6. D.S. McLaren, J.G. Bitar, and V.H. Nassar Protein-calorie malnutrition and the liver Prog. Liver Dis. 4 1972 527 536
7. S.Q. Yang, H.Z. Lin, M.D. Lane, M. Clemens, and A.M. Diehl Obesity increases sensitivity to endotoxin liver injury: implication for the pathogenesis of steatohepatitis Proc. Natl. Acad. Sci. U. S. A. 94 1997 2557 2562
8. M. Vigano, A. Vergani, P. Trombini, F. Paleari, and A. Piperno Insulin resistance influence iron metabolism and hepatic steatosis in type II diabetes Gastroenterology 118 2000 986 987
9. R.J. Sokol, D. Twedt, and J.M. McKim Oxidant injury to hepatic mitochondria in patients with Wilson's disease and Bedlington Terriers with copper toxicosis Gastroenterology 107 1994 1789 1798
10. L. Rubbia-Brandt, G. Leandro, and L. Spahr Liver steatosis in chronic hepatitis C: a morphological sign suggesting infection with HCV genotype 3 Histopathology 39 2001 119 124
11. G. Bianchi, G. Marchesini, and M. Zoli Prognostic significance of diabetes in patients with cirrhosis Hepatology 20 1994 119 125
12. D.H. Alpers, S.M. Sabesin, and H.M. White Fatty liver; biochemical and clinical aspects L. Shiff E. Shiff Disease of the liver 1993 Lippincott Philadelphia 825 855
13. C. Spycher, A. Zimmermann, and J. Reichen The diagnostic value of liver biopsy BMC Gastroenterol. 1 2001 12 17
14. A.J. Sanyal, C. Campbell-Sargent, and F. Mirshahi Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities Gastroenterology 120 2001 1183 1192
15. J. Choudhury, and A.J. Sanyal Insulin resistance and the pathogenesis of nonalcoholic fatty liver disease Clin. Liver Dis. 8 2004 575 594
16. S. Chitturi, and G.C. Farrell Etiopathogenesis of non-alcoholic steatohepatitis Semin. Liver Dis. 21 2001 27 41
17. G. Robertson, I. Leclercq, and G.C. Farrell Nonalcoholic steatosis and steatohepatitis. II. Cytochrome P-450 enzymes and oxidative stress Am. J. Physiol.: Gastrointest. Liver Physiol. 281 2001 G1135 G1139
18. J.C. Fernandez-Checa, N. Kaplowitz, C. Garcia-Ruiz, and A. Colell Mitochondrial glutathione: importance and transport Semin. Liver Dis. 18 1998 389 401
19. M.D. Jensen, M.W. Haymond, R.A. Rizza, P.E. Cryer, and J.M. Miles Influence of body fat distribution on free fatty acid metabolism in obesity J. Clin. Invest. 83 1989 1168 1173
20. I.R. Wanless, and J.S. Lentz Fatty liver hepatitis (steatohepatitis) and obesity: an autopsy study with analysis of risk factors Hepatology 12 1990 1106 1110
21. S. Chitturi, S. Abeygunasekera, and G.C. Farrell NASH and insulin resistance: insulin hypersecretion and specific association with the insulin resistance syndrome Hepatology 35 2002 373 379
22. B.B. Khan, and J. Flier Obesity and insulin resistance J. Clin. Invest. 106 2000 473 481
23. J.K. Kim, Y.J. Kim, and J.J. Fillmore Prevention of fat-induced insulin resistance by salicylate J. Clin. Invest. 108 2001 437 446
24. D.G. Carey, A.B. Jenkins, and L.V. Campbell Abdominal fat and insulin resistance in normal and overweight women: direct measurements reveal a strong relationship in subjects at both low and high risk of NIDDM Diabetes 45 1996 633 638
25. M. Roden Non-invasive studies of glycogen metabolism in human skeletal muscle using nuclear magnetic resonance spectroscopy Curr. Opin. Clin. Nutr. Metab. Care 4 2001 261 266
26. L.M. Obeid, C.M. Linardic, and L.A. Karolak Programmed cell death induced by ceramide Science 259 1993 1769 1771
27. J.M. Friedman, and J.L. Halaas Leptin and the regulation of body weight in mammals Nature 395 1998 763 770
28. A. Enriquez, I. Leclercq, G.C. Farrell, and G. Robertson Altered expression of hepatic CYP2E1 and CYP4A in obese, diabetic ob/ob mice and fa/fa Zucker rats Biochim. Biophys. Res. Commun. 255 1999 300 306
29. I. Leclercq, J. Field, A. Erriquez, G.C. Farrell, and G. Robertson Constitutive and inducible expression of hepatic CYP2E1 and CYP4A in leptin-deficient ob/ob mice Biochim. Biophys. Res. Commun. 268 2000 337 344
30. M.G. Emery, J.M. Fisher, and J.Y. Chien CYP2E1 activity before and after weight loss in morbidly obese subjects with nonalcoholic fatty livers disease Hepatology 38 2003 428 435
31. S. Kersten, J. Seydoux, and J.M. Peters Peroxisome proliferator-activated receptor alpha mediates the adaptive response to fasting J. Clin. Invest. 103 1999 1489 1498
32. N.M. Bass Three for the price of one knockout-A mouse model of congenital peroxisomal disorder, steatohepatitis, and hepatic carcinogenesis Hepatology 29 1999 606 608
33. J.K. Reddy Nonalcoholic steatosis and steatohepatitis III. Peroxisomal β-oxidation, PPARα, and steatohepatitis Am. J. Physiol.: Gastrointest. Liver Physiol. 281 2001 G1333 G1339
34. M.S. Rao, and J.K. Reddy Peroxisomal β-oxidation and steatohepatitis Semin. Liver Dis. 21 2001 43 56
35. G. Ekstrom, and M. Ingelman-Sundberg Rat-liver microsomal NADPH-supported oxidase activity and lipid peroxidation dependent on ethanol-inducible cytochrome P-450 (P-450 IIE1) Biochem. Pharmacol. 38 1989 1313 1319
36. C.S. Lieber Cytochrome P-4502E1: its physiological and pathological role Physiol. Rev. 77 1997 517 544
37. M.D. Weltman, G.C. Farrell, P. Hall, M. Ingelman-Sundberg, and C. Liddle Hepatic cytochrome P450 2E1 is increased in patients with non-alcoholic steatohepatitis Hepatology 27 1998 128 233
38. M.D. Weltman, G.C. Farrell, and C. Liddle Increased hepatocyte CYP2E1 expression in a rat nutritional model of hepatic steatosis with inflammation Gastroenterology 111 1996 1645 1653
39. D.G. Fong, V. Nehra, K.D. Lindor, and A.L. Buchman Metabolic and nutritional considerations in non-alcoholic fatty liver Hepatology 32 2000 3 10
40. T. Hashimoto, T. Fujika, and N. Usuda Peroxisomal and mitochondrial fatty acid β oxidation in mice nullizygous for both peroxisome proliferator-activated receptor β and peroxisomal fatty acyl-CoA oxidase J. Biol. Chem. 274 1999 19228 19236
41. C.S. Lieber Biochemical and molecular basis of alcohol-induced injury to liver and other tissues N. Engl. J. Med. 319 1988 1639 1646
42. M.U. Dianzani, G. Muzio, M.E. Biocca, and R.A. Canuto Lipid peroxidation in fatty liver induced by caffeine in rats Int. J. Tissue React. 13 1991 79 85
43. A.K. Ghoshal, and E. Farber Choline deficiency, lipotrope deficiency and the development of liver disease including liver cancer: a new perspective Lab. Invest. 68 1993 255 260
44. H. Tsukamoto, W. Horne, and S. Kamimura Experimental liver cirrhosis induced by alcohol and iron J. Clin. Invest. 96 1995 620 630
45. I. Grattagliano, G. Vendemiale, and B.H. Lauterburg Reperfusion injury of the liver: role of mitochondria and protection by glutathione ester J. Surg. Res. 86 1999 2 8
46. R. Pascale, L. Pirisi, and L. Daino Role of phosphatidylethanolamine methylation in the synthesis of phosphatidylcholine by hepatocytes isolated from coline deficient rats FEBS Lett. 145 1982 293 397
47. H.E. Poulsen, L. Ranek, and P.B. Andreasen The hepatic glutathione content in liver diseases Scand. J. Clin. Lab. Invest. 41 1981 573 576
48. I. Grattagliano, G. Vendemiale, and P. Caraceni Starvation impairs antioxidant defense in fatty livers of rats fed a choline-deficient diet J. Nutr. 130 2000 2131 2136
49. A.M. Hoyumpa, H.C. Greene, D.G. Dunn, and S.D.D. Schenker Fatty liver: biochemical and clinical considerations Dig. Dis. 20 1975 1142 1149
50. R.S. Strauss Comparison of serum concentrations of α-tocopherol and β-carotene in a cross-sectional sample of obese and nonobese children (NHANES III) J. Pediatr. 134 1999 160 165
51. H. Jaeschke, A.P. Bautista, Z. Spolarics, and J.J. Spitzer Superoxide generation by Kupffer cells and priming of neutrophils during reperfusion after hepatic ischemia Free Radic. Res. Commun. 15 1991 277 284
52. H. Jaeschke Vascular oxidant stress and hepatic ischemia/reperfusion injury Free Radic. Res. Commun. 12 1991 737 743
53. B. Nardo, P. Caraceni, and P. Parisi Increased generation of reactive oxygen species in isolated rat fatty liver during postischemic reoxygenation Transplantation 71 2001 1816 1820
54. C. Zhang, L.M. Walker, J.A. Hinson, and P.R. Mayeux Oxidant stress in rat liver after lipopolysaccharide administration: effect of inducible nitric-oxide synthase inhibition J. Pharmacol. Exp. Ther. 293 2000 968 972
55. B. Nardo, I. Grattagliano, and M. Domenicali Mitochondrial oxidative injury in rat fatty livers exposed to warm ischemia-reperfusion Transplant. Proc. 32 2000 51
56. K. Soltys, G. Dikdan, and B. Koneru Oxidative stress in fatty livers of obese Zucker rats: rapid amelioration and improved tolerance to warm Ischemia with tocopherol Hepatology 34 2001 13 18
57. H.Z. Lin, S.Q. Yang, F. Kujhada, G. Ronnet, and A.M. Diehl Metformin reverses fatty liver disease in obese, leptin deficient mice Nat. Med. 6 2000 998 1003
58. J.R. Lancaster, S.M. Taster, and L.R. Gooding Inhibition of target cell mitochondrial electron transfer by tumour necrosis factor FEBS Lett. 248 1989 169 174
59. D. Pessayre, G. Feldmann, and D. Haouzi Hepatocyte apoptosis triggered by natural substances (cytokines, other endogenous substances and foreign toxins) R.G. Cameron G. Feuer Apoptosis and its modulation by drugs Handbook Exp. Pharmacol. vol. 142 2000 Springer Heidelberg 59 108
60. L. Valenti, A.L. Fracanzani, and P. Dongiovanni Tumor necrosis factor α promoter polymorphisms and insulin resistance in nonalcoholic fatty liver disease Gastroenterology 122 2002 274 280
61. G. Leonarduzzi, A. Scavazza, and F. Biasi The lipid peroxidation end product 4-hydroxy-2,3-nonenal up-regulates transforming growth factor β1 expression in the macrophage lineage: a link between oxidative injury and fibrosclerosis FASEB J. 11 1997 851 857
62. S. Strand, W.J. Hofmann, and A. Grambihler Hepatic failure and liver cell damage in acute Wilson's disease involve CD95 (APO-1/Fas) mediated apoptosis Nat. Med. 4 1998 588 593
63. H.L. Bonkovsky, Q. Jawaid, and K. Tortorelli Non-alcoholic steatohepatitis and iron: increased prevalence of mutations of the HFE gene in non-alcoholic steatohepatitis J. Hepatol. 31 1999 421 429
64. P. Stal, H. Glaumann, and R. Hultcrantz Liver cell damage and lysosomal iron storage in patients with idiopathic hemochromatosis J. Hepatol. 11 1990 172 180
65. S.H. Caldwell, R.H. Swerdlow, and E.M. Khan Mitochondrial abnormalities in non-alcoholic steatohepatitis J. Hepatol. 31 1999 430 434
66. A. Berson, V. De Beco, and P. Letteron Steatohepatitis-inducing drugs cause mitochondrial dysfunction and lipid peroxidation in rat hepatocytes Gastroenterology 114 1998 764 774
67. G. Vendemiale, I. Grattagliano, A. Signorile, and E. Altomare Ethanol-induced changes of intracellular thiol compartmentation and protein redox status in the rat liver: effect of tauroursodeoxycholate J. Hepatol. 28 1998 46 53
68. B. Fromenty, C. Fisch, and C. Labbe Amiodarone inhibits the mitochondrial β-oxidation of fatty acids and produces microvesicular steatosis of the liver in mice J. Pharmacol. Exp. Ther. 255 1990 1371 1376
69. 13C-ketoisocaproate breath test J. Lab. Clin. Med. 125 1995 378 383
70. T. Minor, S. Akbar, R. Tolba, and F. Dombrowski Cold preservation of fatty liver grafts: prevention of functional and ultrastructural impairments by venous oxygen persufflation J. Hepatol. 32 2000 105 111
71. C. Miki, K. Iryama, and D.F. Mirza Postperfusion energy metabolism of steatotic graft viability following liver transplantation Dig. Dis. Sci. 43 1998 74 79
72. 2 generation in liver mitochondria Carcinogenesis 21 2000 983 989
73. G. Vendemiale, I. Grattagliano, and P. Caraceni Mitochondrial oxidative injury and energy metabolism alteration in rat fatty liver: effect of the nutritional status Hepatology 33 2001 808 815
74. D. Pessayre, A. Berson, B. Fromenty, and A. Mansouri Mitochondria in steatohepatitis Semin. Liver Dis. 21 2001 57 69
75. M. Perez-Carreras, P. Del Hoyo, and M.A. Martin Defective hepatic mitochondrial respiratory chain in patients with nonalcoholic steatohepatitis Hepatology 38 2003 999 1007
76. I. Grattagliano, P. Caraceni, and P. Portincasa Adaptation of subcellular glutathione detoxification system to stress conditions in choline-deficient diet induced rat fatty liver Cell Biol. Toxicol. 19 2003 355 366
77. S.F. Solga, and A.M. Diehl Non-alcoholic fatty liver disease: lumen-liver interactions and possible role for probiotics J. Hepatol. 38 2003 681 687
78. K. Cope, T.H. Risby, and A.M. Diehl Increased gastrointestinal ethanol production in obese mice: implications for fatty liver disease pathogenesis Gastroenterology 119 2000 1399 1401
79. S.Q. Yang, H. Zhu, and Y. Li Mitochondrial adaptations to obesity-related oxidant stress Arch. Biochem. Biophys. 378 2000 259 268
80. M.P. Hocking Long-term consequences after jejunalileal bypass for morbid obesity Dig. Dis. Sci. 43 1998 2493 2499
81. G.N. Verne, and C.A. Sninsky Diabetes and the gastrointestinal tract Gastroenterol. Clin. North Am. 27 1998 861 874
82. M.D. Crowell, L.J. Cheskin, and F. Musial Prevalence of gastrointestinal symptoms in obese and normal weight binge eaters Am. J. Gastroenterol. 89 1994 387 391
83. Z. Li, S. Yang, and H. Lin Probiotics and antibodies to TNFα inhibit inflammatory activity and improve nonalcoholic fatty liver disease Hepatology 37 2003 343 350
84. S. Eriksson, K.F. Eriksson, and L. Bondesson Nonalcoholic steatohepatitis in obesity: a reversible condition Acta Med. Scand. 220 1986 83 88
85. E.J. Drenick, J. Fisler, and D. Johnson Hepatic steatosis after intestinal bypass. Prevention and reversal by metronidazole irrespective of protein-calorie malnutrition Gastroenterology 83 1982 534 548
86. P. Caraceni, B. Nardo, and M. Domenicali Ischemia-reperfusion injury in the rat fatty liver: role of nutritional status Hepatology 29 1999 1139 1146
87. P. Caraceni, H.S. Ryu, and V. Subbotin Rat hepatocytes isolated from alcohol-induced fatty liver have an increased sensitivity to anoxic injury Hepatology 25 1997 943 949
88. J. Martensson The effect of fasting on leukocyte and plasma glutathione and sulfur amino acid concentrations Metabolism 35 1996 118 121
89. P. Di Simplicio, R. Rossi, S. Falcinelli, R. Ceserani, and M.L. Formento Antioxidant status in various tissue of the mouse after fasting and swimming Eur. J. Appl. Physiol. 76 1997 302 307
90. J.M. Saudubray, D. Martin, and P. de Lonlay Recognition and management of fatty acid oxidation defects: a series of 107 patients J. Inherit. Metab. Dis. 22 1999 488 502
91. B. Fromenty, and D. Pessayre Inhibition of mitochondrial beta-oxidation as a mechanism of hepatotoxicity Pharmacol. Ther. 67 1995 101 154
92. N.J. Watmough, L.A. Bindoff, and M.A. Birch-Machin Impaired mitochondrial β-oxidation in a patient with an abnormality of the respiratory chain. Studies in skeletal muscle mitochondria J. Clin. Invest. 85 1990 177 184
93. M. Domenicali, P. Caraceni, and G. Vendemiale Food deprivation exacerbates mitochondrial oxidative stress in rat liver exposed to ischemia-reperfusion injury J. Nutr. 131 2001 105 110
94. G. Musso, R. Gambino, and F. De Michieli Dietary habits and their relation to insulin resistance and postprandial lipemia in non-alcoholic steatohepatitis Hepatology 37 2003 909 916
95. B.G. Rosser, and G.J. Gores Liver cell necrosis: cellular mechanisms and clinical implications Gastroenterology 108 1995 252 275
96. L. Bortenshlager, P.R. Roberts, K.W. Black, and G.P. Zaloga Enteral feeding minimizes liver injury during hemorrhagic shock Shock 2 1994 351 354
97. R. Cywes, P.D. Greig, and J.R. Sanabria Effect of intraportal glucose infusion on hepatic glycogen content and degradation, and outcome of liver transplantation Ann. Surg. 216 1992 235 246
98. I. Grattagliano, P. Portincasa, and P. Caraceni Experimental observations and clinical implications of fasting and diet supplementation in fatty livers Eur. Rev. Med. Pharmacol. Sci. 7 2003 1 7
99. M. Selzner, and P.A. Clavien Failure of regeneration of the steatotic rat liver: disruption at two different levels in the regeneration pathway Hepatology 31 2000 35 42
100. R.S. Britton, R. O'Neill, and B.R. Bacon Hepatic mitochondrial malondialdehyde metabolism in rats with chronic iron overload Hepatology 11 1990 93 97
101. J.C. Fernandez-Checa, C. Garcia-Ruiz, M. Ooktens, and N. Kaplowitz Impaired uptake of glutathione by hepatic mitochondria from chronic ethanol-fed rats J. Clin. Invest. 87 1991 397 405
102. S.Q. Yang, H.Z. Lin, A.K. Mandal, J. Huang, and A.M. Diehl Disrupted signaling and inhibited regeneration in obese mice with fatty livers: implications for non-alcoholic fatty liver disease pathophysiology Hepatology 34 2001 694 706
103. C. Picard, L. Lambotte, and P. Starkel Steatosis is not sufficient to cause an impaired regenerative response after partial hepatectomy in rats J. Hepatol. 36 2002 645 652
104. B.G. Devi, G.I. Henderson, T.A. Frosto, and S. Schenker Effect of ethanol on rat fetal hepatocytes: studies on cell replication, lipid peroxidation and glutathione Hepatology 18 1993 648 659
105. 1-ATP synthase and low regenerating capability of the liver after partial hepatectomy in hypothyroid rats J. Bioenerg. Biomembr. 32 2000 183 191
106. I. Grattagliano, B.H. Lauterburg, and P. Portincasa Mitochondrial glutathione content determines the rate of liver regeneration after partial hepatectomy in eu- and hypothyroid rats J. Hepatol. 39 2003 571 579
107. B.H. Zhang, M. Weltman, and G.C. Farrell Does steatohepatitis impair liver regeneration? A study in a dietary model of non-alcoholic steatohepatitis in rats J. Gastroenterol. Hepatol. 14 1999 133 137
108. B. Akhurst, E.J. Croager, and C.A. Farley-Roche A modified choline-deficient, ethionine-supplemented diet protocol effectively induces oval cells in mouse liver Hepatology 34 2001 519 522
109. A.E. Feldstein, A. Canbay, and P. Angulo Hepatocyte apoptosis and fas expression are prominent features of human nonalcoholic steatohepatitis Gastroenterology 125 2003 437 443
110. G.A. Abrams, S.S. Kunde, and A.J. Lazenby Portal fibrosis and hepatic steatosis in morbidly obese subjects: a spectrum of nonalcoholic fatty liver disease Hepatology 40 2004 475 483
111. B.A. Neuschwander-Tetri, and S.H. Caldwell Nonalcoholic steatohepatitis: summary of an AASLD single topic conference Hepatology 37 2003 1202 1219
112. G. Marchesini, E. Bugianesi, and G. Forlani Non alcoholic fatty liver steatohepatitis and the metabolic syndrome Hepatology 37 2003 917 923
113. W.B. Salt Nonalcoholic fatty liver disease (NAFLD): a comprehensive review J. Insur. Med. 36 2004 27 41
114. R.S. Strauss, S.E. Barlow, and W.H. Dietz Prevalence of abnormal serum aminotransferase values in overweight and obese adolescents J. Pediatr. 136 2000 727 735
115. E.A. Roberts Nonalcoholic steatohepatitis in children Curr. Gastroenterol. Rep. 5 2003 253 259
116. C.S. Yensel, D. Preud'homme, and D.M. Curry Childhood obesity and insulin-resistant syndrome J. Pediatr. Nurs. 19 2004 238 246
117. J.P. Molleston, F. White, and J. Teckman Obese children with steatohepatitis can develop cirrhosis in childhood Am. J. Gastroenterol. 97 2002 2460 2462
118. A.W. Marion, A.J. Baker, and A. Dhawan Fatty liver disease in children Arch. Dis. Child. 89 2004 648 652
119. G. Marchesini, M. Brizi, and A.M. Morselli-Labate Association of non-alcoholic fatty liver disease with insulin resistance Am. J. Med. 107 1999 450 455
120. J.F. Silverman, K.F. O'Brien, and S. Long Liver pathology in morbidly obese patients with and without diabetes Am. J. Gastroenterol. 85 1990 1349 1355
121. G. Donati, B. Stagni, and F. Piscaglia Increased prevalence of fatty liver in arterial hypertensive patients with normal liver enzymes: role of insulin resistance Gut 2004
122. A.M. Diehl Fatty liver, hypertension, and the metabolic syndrome Gut 53 2004 923 924
123. V.M.D. Struben, E.E. Hespenheide, and S. Caldwell Nonalcoholic steatohepatitis and cryptogenic cirrhosis within kindreds Am. J. Med. 108 2000 9 13
124. I.R. Willner, B. Waters, and S.R. Patil Ninety patients with nonalcoholic steatohepatitis: insulin resistance, family tendency, and severity of disease Am. J. Gastroenterol. 96 2001 2957 2961
125. F. Marra NASH: are genes blowing the hits? J. Hepatol. 40 2004 853 856
126. E.A. Oral, V. Simha, and E. Ruiz Leptin-replacement therapy for lipodystrophy N. Engl. J. Med. 346 2002 570 578
127. K.F. Petersen, E.A. Oral, and S. Dufour Leptin reverses insulin resistance and hepatic steatosis in patients with severe lipodystrophy J. Clin. Invest. 109 2002 1285 1286
128. N. Barzilai, J. Wang, and D. Massilon Leptin selectively decreases visceral adiposity and enhances insulin action J. Clin. Invest. 100 1997 3105 3110
129. E.E. Powell, W.E.G. Cooksley, and R. Hanson The natural history of non-alcoholic steatohepatitis: a follow-up study of forty-two patients for up to 21 years Hepatology 11 1990 74 80
130. S.H. Caldwell, and D.M. Crespo The spectrum expanded: cryptogenic cirrhosis and the natural history of non-alcoholic fatty liver disease J. Hepatol. 40 2004 578 584
131. V. Ratziu, L. Bonyhay, and V. Di Martino Survival, liver failure, and hepatocellular carcinoma in obesity-related cryptogenic cirrhosis Hepatology 35 2002 1485 1493
132. D.H. Lawson, J.M. Gray, and C. McKillop Diabetes mellitus and primary hepatocellular carcinoma Q. J. Med. 61 1986 945 955
133. H.B. El-serag, T. Tran, and J.E. Everhart Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma Gastroenterology 2004 126
134. R. Bencheqroun, C. Duvoux, and A. Luciani Hepatocellular carcinoma without cirrhosis in a patient with non-alcoholic steatohepatitis Gastroenterol. Clin. Biol. 28 2004 497 499
135. A. Sanjeevi, E. Lyden, and B. Sunderman Outcomes of liver transplantation for cryptogenic cirrhosis: a single-center study of 71 patients Transplant. Proc. 35 2003 2977 2980
136. 2 generation in liver mitochondria Carcinogenesis 21 2000 983 989
137. S. Yang, H.Z. Lin, and J. Hwang Hepatic hyperplasia in noncirrhotic fatty livers: is obesity-related hepatic steatosis a premalignant condition? Cancer Res. 61 2001 5016 5023
138. A.M. Di Bisceglie, R.L. Carithers, and G.J. Gores Hepatocellular carcinoma Hepatology 28 1998 1161 1165
139. J.A. Marrero, R.J. Fontana, and G.L. Su NAFLD may be a common underlying liver disease in patients with hepatocellular carcinoma in the US Hepatology 36 2002 1349 1354
140. C. Loguercio, V. De Girolamo, and I. de Sio Non-alcoholic fatty liver disease in an area of southern Italy: main clinical, histological, and pathophysiological aspects J. Hepatol. 35 2001 568 574
141. C. Loguercio, T. De Simone, and M.V. D'Auria Non-alcoholic fatty liver disease: a multicentre clinical study by the Italian Association for the Study of the Liver Dig. Liver Dis. 36 2004 398 405
142. B.R. Bacon, M.J. Farahvash, C.G. Janney, and B.A. Neuschwander-Tetri Nonalcoholic steatohepatitis: an expanded clinical entity Gastroenterology 107 1994 1103 1109
143. American Diabetes Association Consensus development conference on insulin resistance Diabetes Care 21 1998 310 314
144. S.M. Haffner, H. Miettinen, and M.P. Stem The homeostasis model in the San Antonio heart study Diabetes Care 20 1997 1087 1092
145. J.B. Dixon, P.S. Bhathal, and P.E. O'Brien Nonalcoholic fatty liver disease: predictors of non-alcoholic steatohepatitis and liver fibrosis in the severely obese Gastroenterology 121 2001 91 100
146. G. Pagano, G. Pacini, and G. Musso Nonalcoholic steatohepatitis, insulin resistance, metabolic syndrome: further evidence for an etiologic association Hepatology 35 2002 367 372
147. R.J. Davies, S.H. Saverymuttu, and M. Fallowfield Paradoxical lack of ultrasound attenuation with gross fatty changes in the liver Clin. Radiol. 43 1991 393 396
148. S. Saadeh, Z.M. Younossi, and E.M. Remer The utility of radiological imaging in non-alcoholic fatty liver disease Gastroenterology 123 2002 745 750
149. S.A. Harrison, S. Torgenson, and P.H. Hayashi The natural history of nonalcoholic fatty liver disease: a clinical histopathological study Am. J. Gastroenterol. 98 2003 2042 2047
150. P. Angulo, J.C. Keach, K.P. Batts, and K.D. Lindor Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis Hepatology 30 1999 1356 1362
151. V. Ratziu, P. Giral, and F. Charlotte Liver fibrosis in overweight patients Gastroenterology 118 2000 1117 1123
152. F. Lainè, C. Bendavid, and R. Moirand Prediction of liver fibrosis in patients with features of the metabolic syndrome regardless of alcohol consumption Hepatology 39 2004 1639 1646
153. S. Fargion, M. Mattioli, and A.L. Fracanzani Hyperferritinemia, iron overload, and metabolic alterations identify patients at risk for nonalcoholic steatohepatitis Am. J. Gastroenterol. 96 2001 2448 2455
154. F. Mion, M. Rousseau, J.L. Brazier, and Y. Minaire Human hepatic macrovesicular steatosis: a noninvasive study of mitochondrial ketoisocaproic acid decarboxylation Metabolism 44 1995 699 700
155. P.A. Michaeletz, L. Cap, E. Alpert, and B.H. Lauterburg Assessment of mitochondrial function in vivo with a breath test utilizing α- ketoisocaproic acid Hepatology 10 1989 829 832
156. 13C-methionine breath test in patients with macrovesicular steatosis and patients with cirrhosis Med. Sci. Monit. 9 2003 CR6 CR11
157. A. Armuzzi, M. Candelli, and M.A. Zocco Breath testing for human liver function assessment Aliment. Pharmacol. Ther. 16 2002 1977 1996
158. R.J. De Knegt Non-alcoholic steatohepatitis: clinical significance and pathogenesis Scand. J. Gastroenterol. 36 2001 88 92
159. A.T. Marubbio, H. Buchwald, M.Z. Schwartz, and R. Varco Hepatic lesions of pericellular fibrosis in morbid obesity, and after jejunoileal bypass Am. J. Clin. Pathol. 66 1976 684 691
160. J.B. Dixon, P.S. Bhathal, N.R. Hughes, and P.E. O'Brien Nonalcoholic fatty liver disease: improvement in liver histological analysis with weight loss Hepatology 39 2004 1647 1654
161. Z.M. Younossi, T. Gramlich, C.A. Matteoni, N. Boparai, and A.J. McCullough Nonalcoholic fatty liver disease in patients with type 2 diabetes Clin. Gastroenterol. Hepatol. 2 2004 262 265
162. E. Ferrannini, E.J. Barrett, S. Bevilaqua, and R.A. DeFronzo Effects of free fatty acids on glucose production and utilization in man J. Clin. Invest. 72 1983 1737 1747
163. A. Lombes, J.R. Mendell, and H. Nakase Myoclonic epilepsy and ragged-red fibers with cytochrome oxidase deficiency: neuro-pathology, biochemistry and molecular genetics Ann. Neurol. 26 1989 20 33
164. N.G. Larsson, and D. Clayton Molecular genetic aspects of human mitochondrial disorders Annu. Rev. Genet. 29 1995 151 178
165. A. Uygun, A. Kadayifci, and Isik At Metformin in the treatment of patients with non-alcoholic steatohepatitis Aliment. Pharmacol. Ther. 19 2004 537 544
166. B.A. Neuschwander-Tetri, E.M. Brunt, K.R. Wehmeier, D. Oliver, and B.R. Bacon Improved non-alcoholic steatohepatitits after 48 weeks of treatment with the PPAR-γ ligand rosiglitazone Hepatology 38 2003 1008 1017
167. H. Yoshida, and G. Kajimoto Effect of dietary vitamin E on the toxicity of autoxidized oil to rats Ann. Nutr. Metab. 33 1989 153 161
168. H. Nakano, H. Nagasaki, and A. Barama The effects of N-acetylcysteine and anti-intercellular adhesion molecule-1 monoclonal antibody against ischemia-reperfusion injury of rat steatotic liver produced by a choline methionine-deficient diet Hepatology 26 1997 670 678
169. P. Angulo, and D.K. Lindor Insulin resistance and mitochondrial abnormalities in NASH: a cool look into a burning issue Gastroenterology 120 2001 1281 1285
170. Y. Kaneshiro, H. Nakano, and K. Kumada Augmentation of mitochondrial reduced glutathione by S-adenosyl-methionine administration in ischemia-reperfusion injury of the rat steatotic liver induced by choline-methionine deficient diet Eur. Surg. Res. 30 1998 34 42
171. J.E. Lavine Vitamin E treatment of non-alcoholic steatohepatitis in children: a pilot study J. Pediatr. 136 2000 734 738
172. T. Hasegawa, M. Yoneda, and K. Nakamura Plasma transforming factor-b1 level and efficacy of α-tocopherol in patients with non-alcoholic steatohepatitis: a pilot study Aliment. Pharmacol. Ther. 15 2001 1667 1672
173. C. Loguercio, T. De Simone, and A. Federicio Gut-liver axis: a new point of attack to treat chronic liver damage? Am. J. Gastroenterol. 97 2002 2144 2146
174. L. Seeff, K.L. Lindsay, B.R. Bacon, T.F. Kresina, and J.H. Hoofnagle Complementary and alternative medicine in chronic liver disease Hepatology 34 2001 595 603
175. A. Okan, H. Astarcioglu, and E. Tankurt Effect of ursodeoxycholic acid on hepatic steatosis in rats Dig. Dis. Sci. 47 2002 2389 2397
176. K.D. Lindor, K.V. Kowdley, and J. Heathcote Ursodeoxycholic acid for treatment of nonalcoholic steatohepatitis: results of a randomized trials Hepatology 39 2004 770 778
177. M.S. Rao, K. Papreddy, S. Musunmi, and A. Okonkwo Prevention/reversal of choline deficiency-induced steatohepatitis by a peroxisome proliferator- activated receptor alpha ligands in rats In Vivo 16 2002 145 152
178. J.R. Levy, J.N. Clore, and W. Stevens Dietary n-3 polyunsaturated fatty acids decrease hepatic triglycerides in Fisher 344 rats Hepatology 39 2004 608 616
179. M. Abdelmalek, P. Angulo, R.A. Jorgensen, P.B. Sylvestre, and K. Lindor Betaine, a promising new agent for patients with non-alcoholic steatohepatitis: results of a pilot study Am. J. Gastroenterol. 96 2001 2711 2717
180. R. Weiner, H. Gutberlet, and H. Bockhorn Preparation of extremely obese patients for laparoscopic gastric banding by gastric-balloon therapy Obes. Surg. 9 1999 261 264
181. R.M. Molloy, R. Komorowski, and R.R. Varma Recurrent non-alcoholic steatohepatitis and cirrhosis after liver transplantation J. Liver Transpl. Surg. 3 1997 177 178
182. M.J. Contos, W. Cales, and R.K. Sterling Development of non-alcoholic fatty liver disease after orthotopic liver transplantation for cryptogenic cirrhosis Liver Transpl. 7 2001 363 373
183. J. Ong, Z.M. Younossi, and V. Reddy Cryptogenic cirrhosis and posttransplantation nonalcoholic fatty liver disease Liver Transpl. 7 2001 797 801
184. H. Thaler Die Fettleber und ihre pathogenetische Beziehung zur Leberzirrhose Virchows Arch. 335 1962 180 210
185. E.M. Brunt, C.G. Janney, A.M. Di Bisceglie, B.A. Neuschwander-Tetri, and B.R. Bacon Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions Am. J. Gastroenterol. 94 1999 2467 2474
186. K. Promrat, G. Lutchman, and G.I. Uwaifo A pilot study of pioglitazone treatment for nonalcoholic steatohepatitis Hepatology 39 2004 188 196
187. M. Basaranoglu, O. Acbay, and A. Sonsuz A controlled trial of gemfibrozil in the treatment of patients with nonalcoholic steatohepatitis J. Hepatol. 31 1999 384